Skip to main content

Table 1 Primer sequences used for this study

From: Comparative genetic characterization of CMY-2-type beta-lactamase producing pathogenic Escherichia coli isolated from humans and pigs suffering from diarrhea in Korea

Target gene

Sequence (5’ → 3’)

Size (bp)

References

B-lactamases

 TEM

F: CATTTCCGTGTCGCCCTTATTC

800

[18]

 

R: CGTTCATCCATAGTTGCCTGAC

 SHV

F: AGCCGCTTGAGCAAATTAAAC

713

[18]

 

R: ATCCCGCAGATAAATCACCAC

 OXA

F: GGCACCAGATTCAACTTTCAAG

564

[18]

 

R: GACCCCAAGTTTCCTGTAAGTG

 CTX-M group 1

F: TTAGGAARTGTGCCGCTGYA

688

[18]

 

R: CGATATCGTTGGTGGTRCCAT

 CTX-M group 2

F: CGTTAACGGCACGATGAC

404

[18]

 

R: CGATATCGTTGGTGGTRCCAT

 CTX-M group 9

F: TCAAGCCTGCCGATCTGGT

561

[18]

 

R: TGATTCTCGCCGCTGAAG

 CTX-M group 8/25

F: AACRCRCAGACGCTCTAC

326

[18]

 

R: TCGAGCCGGAASGTGTYAT

 ACC

F: CACCTCCAGCGACTTGTTAC

346

[18]

 

R: GTTAGCCAGCATCACGATCC

 FOX

F: CTACAGTGCGGGTGGTTT

162

[18]

 

R: CTATTTGCGGCCAGGTGA

 MOX

F: GCAACAACGACAATCCATCCT

895

[18]

 

R: GGGATAGGCGTAACTCTCCCAA

 CIT

F: CGAAGAGGCAATGACCAGAC

538

[18]

 

R: ACGGACAGGGTTAGGATAGY

 DHA

F: TGATGGCACAGCAGGATATTC

997

[18]

 

R: GCTTTGACTCTTTCGGTATTCG

 EBC

F: CGGTAAAGCCGATGTTGCG

683

[18]

 

R: AGCCTAACCCCTGATACA

 GES

F: AGTCGGCTAGACCGGAAAG

399

[18]

 

R: TTTGTCCGTGCTCAGGAT

 PER

F: GCTCCGATAATGAAAGCGT

520

[18]

 

R: TTCGGCTTGACTCGGCTGA

 VEB

F: CATTTCCCGATGCAAAGCGT

648

[18]

 

R: CGAAGTTTCTTTGGACTCTG

Plasmid-mediated quinolone

 qnrA

F: TCAGCAAGAGGATTTCTCA

627

[19]

 

R: GGCAGCACTATTACTCCCA

 qnrB

F: CGACCTGAGCGGCACTGAAT

515

[20]

 

R: TGAGCAACGATGCCTGGTAG

 qnrC

F: GGGTTGTACATTTATTGAATC

447

[21]

 

R: TCCACTTTACGAGGTTCT

 qnrD

F: CGAGATCAATTTACGGGGAATA

582

[22]

 

R: AACAAGCTGAAGCGCCTG

 qnrS

F: ACCTTCACCGCTTGCACATT

571

[20]

 

R: CCAGTGCTTCGAGAATCAGT

 qepA

F: CGTGTTGCTGGAGTTCTTC

403

[23]

 

R: CTGCAGGTACTGCGTCATG

Aminoglycoside-modifying enzymes

 aac(3)-II

F: TGAAACGCTGACGGAGCCTC

369

[24]

R: GTCGAACAGGTAGCACTGAG

 ant(2’’)-I

F: GGGCGCGTCATGGAGGAGTT

740

[24]

R: TATCGCGACCTGAAAGCGGC

Chloramphenicol

 catA1

F: AGTTGCTCAATGTACCTATAACC

547

[25]

R: TTGTAATTCATTAAGCATTCTGCC

 cmlA

F: CCGCCACGGTGTTGTTGTTATC

698

[25]

R: CACCTTGCCTGCCCATCATTAG

Sulfonamide

 sul1

F: CTTCGATGAGAGCCGGCGGC

433

[26]

R: GCAAGGCGGAAACCCGCGCC

 sul2

F: CGGCATCGTCAACATAACC

722

[27]

R: GTGTGCGGATGAAGTCAG

Tetracyclines

 tetA

F: GTAATTCTGAGCACTGTCGC

956

[28]

R: CTGCCTGGACAACATTGCTT

 tetB

F: CTCAGTATTCCAAGCCTTTG

414

[28]

R: ACTCCCCTGAGCTTGAGGGG

 tetC

F: CCTCTTGCGGGATATCGTCC

505

[28]

R: GGTTGAAGGCTCTCAAGGGC

 tetD

F: GGATATCTCACCGCATCTGC

436

[28]

R: CATCCATCCGGAAGTGATAGC

 tetE

F: AAACCACATCCTCCATACGC

278

[28]

R: AAATAGGCCACAACCGTCAG

 tetG

F: GCTCGGTGGTATCTCTGCTC

468

[28]

R: AGCAACAGAATCGGGAACAC

Integrons and cassettes

 Class 1 integron

F: GCCTTGCTGTTCTTCTACGG

558

[29]

R: GATGCCTGCTTGTTCTACGG

 Class 1 cassettes

F: GGCATCCAAGCAGCAAG

variable

[29]

R: AAGCAGACTTGACCTGA

 Class 2 integron

F: CACGGATATGCGACAAAAAGGT

788

[30]

R: GTAGCAAACGAGTGACGAAATG

 Class 2 cassettes

F: CGGGATCCCGGACGGCATGCACGATTTGT

variable

[30]

R: GATGCCATCGCAAGTACGAG